Cromos Pharma, where the patients are

AstraZeneca

Molecular Profiles joins consortium to drive pediatric formulation development

Thursday, January 2, 2014 10:30 AM

A collaborative pharmaceutical project focused on improving the pathway for developing pediatric formulations has been given the go-ahead after successfully securing an innovation grant.

More... »

CRF Health eCOA webinar series

AstraZeneca to acquire Bristol-Myers Squibb share of diabetes alliance assets

Friday, December 20, 2013 11:00 AM

AstraZeneca will acquire the entirety of Bristol-Myers Squibb's interest in the companies' diabetes alliance for $2.7 billion, and up to $1.4 billion in regulatory, launch and sales-related payments. AstraZeneca also has agreed to pay various sales-related royalty payments up until 2025 and may make payments up to $225 million when certain assets are subsequently transferred.

More... »


AstraZeneca donates Brixham Environmental Laboratory to Plymouth University

Monday, December 9, 2013 12:25 PM

AstraZeneca will donate its Environmental Laboratory in Brixham to Plymouth University to ensure the lab continues to serve scientific and research purposes.

More... »

Taigle, SAFE-BioPharma partner

Friday, December 6, 2013 01:00 PM

Taigle, an Irvine, Calif.-based technology company, has partnered with the SAFE-BioPharma Association, which manages the global SAFE-BioPharma digital identity and signature standard. 

More... »

PharmaTimes recognizes top U.S. clinical researchers

Tuesday, November 19, 2013 01:00 PM

Winners of the U.S. Clinical Researcher of the Year competition were announced following an intense finals day hosted by partner SAS at its global headquarters in Cary, N.C.

More... »

U.S. Clinical Researchers of the Year announced

Tuesday, November 12, 2013 08:00 AM

The 2013 U.S. Clinical Researchers of the Year winners have been revealed at the Umstead Hotel in North Carolina, U.S.

More... »

AstraZeneca proposes closing Brixham Environmental Laboratory

Friday, October 25, 2013 11:45 AM

AstraZeneca has announced proposals to close its Environmental Laboratory in Brixham, Devon, U.K. The laboratory, with 71 staff members, provides specialist services to assess the impact of pharmaceuticals and chemicals used by a range of industries on the environment.

More... »

Evotec, AstraZeneca enters alliance for kidney disease

Thursday, October 24, 2013 12:12 PM

Evotec has signed an agreement with AstraZeneca in kidney diseases. Initial focus of the alliance will be exploring compounds and targets with novel mechanisms that have disease-modifying potential for the treatment of chronic kidney disease.

More... »

MedImmune acquires Spirogen, collaborates with ADC Therapeutics

Monday, October 21, 2013 01:39 PM

MedImmune, the global biologics R&D arm of AstraZeneca, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology.

More... »

Report: Rapid growth seen for opioid-induced constipation market

Monday, October 14, 2013 02:12 PM

The opioid-induced constipation (OIC) global market will increase significantly from $144.42 million in 2012 to $1.98 billion by 2017, at a compound annual growth rate (CAGR) of 31.9%, according to forecasts from research and consulting firm GlobalData.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs